|
Market Closed -
Nasdaq
16:00:00 2026-11-05 EST
|
5-day change | 1st Jan Change | ||
| 11.25 USD | -8.39% |
|
-11.97% | +50.00% |
| 10-21 | 4D Molecular Therapeutics, Inc. - Analyst/Investor Day | |
| 10-07 | 4D Molecular Therapeutics Insider Sold Shares Worth $753,937, According to a Recent SEC Filing | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| FDMT | Delayed | |
CBOE
| FDMT | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 14.56 | 16.76 | 15.83 |
| Spread/Res. | -22.73% | -32.88% | -28.93% |
| Spread/Supp. | +4.17% | +34.49% | +53.69% |
| Support | 10.8 | 8.365 | 7.32 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- FDMT Stock
- Charts 4D Molecular Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
